Albuterol Inhaler |
Proventil HFA; Proventil Inhaler; Ventolin Inhaler |
Clinical Trial: Genetic Determinants of the Response to Salbutamol Among Asthma Patients
This study is currently recruiting patients.
Verified by Hadassah Medical Organization August 2004
|
Purpose
The response to salbutamol varies greatly among individuals. Data from previous studies indicate that some of the variability is accounted for by genetic polymorphisms in the gene encoding for the adrenoceptor subtype β2. The current study was designed to evaluate variability in the response to salbutamol among recently diagnosed patients who have not been treated by β2 agonists or corticosteroids.
Lung function tests will be performed prior to and following a single dose administration of salbutamol through inhalation. Additional pharmacodynamic indices will be monitored including pulse and blood pressure. Three samples of plasma will be drawn for the evaluation of salbutamol plasma concentration.
| Condition | Intervention |
|---|---|
| Asthma | Drug: Albuterol |
MedlinePlus related topics: Asthma
Study Type: Interventional
Study Design: Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Pharmacokinetics/Dynamics Study
Official Title: Evaluation of Genetic Factors That May Account for Variability in the Response to Salbutamol Among Patients Suffering from Asthma
Expected Total Enrollment: 150
Eligibility
Inclusion Criteria:
- 18 years and older
- Recently diagnosed as asthmatic
Exclusion Criteria:
- Current treatment by β2 agonist
- Current treatment by corticosteroids
- Acute asthma attack
Location and Contact Information
Israel
Hadassah Medical Organization, Jerusalem, 91120, Israel; Recruiting
Hadas Lemberg, PhD 00 972 2 6777572 lhadas@hadassah.org.il
Yoseph Caraco, MD, Principal Investigator
Yoseph Caraco, MD, Principal Investigator, Hadassah Medical Organization, Jerusalem, Israel
More Information
Last Updated: September 12, 2005
Record first received: September 11, 2005
ClinicalTrials.gov Identifier: NCT00162396
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration
ClinicalTrials.gov processed this record on 2005-09-13
Resources
- Albuterol Inhaler (Drug Digest)
- Proventil HFA (Drug Digest)

Not Signed In -

